Prenatal cardiac intervention (PCI) may favorably alter the in utero course of some congenital heart defects. In our preliminary experience with PCI, fetal hemodynamic instability (FHI) characterized by bradycardia and ventricular dysfunction was common. This study evaluated the pathophysiology, management, and short-term outcomes of FHI during PCI for aortic stenosis with evolving hypoplastic left heart syndrome (HLHS), HLHS with restrictive atrial septum, pulmonary atresia with intact ventricular septum, and hydrops due to structural heart disease. From 2000 to 2006, 83 fetuses underwent PCI, with ventricular access in 63, atrial access in 17, and both in three. FHI occurred in 37 fetuses (45%). FHI was associated with transventricular PCI (all but one case of FHI; p Ͻ 0.001) and large hemopericardium (n ϭ 9; p ϭ 0.07). Prolonged FHI was associated with severe ventricular distortion during ventricular puncture (p ϭ 0.06). FHI was treated with resuscitation medications in 31 of 37 fetuses and resolved in all 37. Five fetuses died within 1 d of PCI: four had FHI and one had a massive hemopericardium. FHI is common and clinically important during transventricular PCI and may be caused by a ventricular reflex or reduced cardiac output from cardiac distortion during ventricular puncture. Hemopericardium may be causative in a subset of fetuses. I n some forms of congenital heart disease, relatively simple obstructive anomalies causing physiologic changes in utero may lead to more serious abnormalities of cardiovascular growth and development. For example, severe left ventricular (LV) outflow obstruction in the early fetus may produce myocardial and hemodynamic abnormalities resulting in growth arrest of the entire left heart complex, culminating in HLHS. Similarly, in fetuses with established HLHS, closure of the foramen ovale may cause left atrial hypertension, with subsequent abnormalities of lung parenchymal and vascular development that contribute to high mortality after birth (1,2). Although such processes have not been well defined, the hypothesis that flow disturbances early in gestation can lead to abnormal cardiac growth is supported by experimental animal data (3-5) and by documented progression of isolated LV or right ventricular (RV) outflow obstruction to ventricular hypoplasia in human fetuses (6,7).In fetuses with such congenital heart defects, PCI may limit the secondary abnormalities of growth or development that result from primary structural anomalies by restoring more normal hemodynamic conditions. Since 2000, we have offered PCI for selected fetuses with (1) severe aortic stenosis (AS) with evolving HLHS, (2) critically restrictive or intact atrial septum and established HLHS, (3) pulmonary atresia with evolving hypoplastic right heart syndrome (HRHS), and (4) hydrops fetalis due to structural heart disease (8 -10).Almost immediately, we observed that FHI characterized by bradycardia and ventricular dysfunction was common during PCI. Although cases of fetal cardiac arrest or bradycardi...